Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Medifast stock in Canada | $219.55

Own Medifast shares in just a few minutes.

Medifast Inc
+ $3.95 ( + 1.83%)

Medifast is a personal services business based in the US. Medifast stocks (MED.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $278.93 – a decrease of 5.87% over the previous week. Medifast employs 713 staff and has a trailing 12-month revenue of around $1.3 billion.

How to buy Medifast stock in Canada

  1. Choose a platform. If you're a beginner, our stock trading table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: MED in this case.
  5. Research Medifast stocks. The platform should provide the latest information available.
  6. Buy your Medifast stocks. It's that simple.

Is it a good time to buy Medifast stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

How has Coronavirus impacted Medifast's stock price?

Since the stock market crash in March caused by coronavirus, Medifast's stock price has had significant positive movement.

Its last market close was $219.55, which is 56.28% up on its pre-crash value of $95.98 and 347.79% up on the lowest point reached during the March crash when the stocks fell as low as $49.03.

If you had bought $1,000 worth of Medifast stocks at the start of February 2020, those stocks would have been worth $565.36 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $2,224.04.

Medifast stock price

Use our graph to track the performance of MED stocks over time.

Medifast stocks at a glance

Information last updated 2021-09-18.
Latest market close$219.55
52-week range$137.181 - $335.1738
50-day moving average $237.3346
200-day moving average $258.4971
Wall St. target price$363.33
PE ratio 17.3215
Dividend yield $5.1 (2.37%)
Earnings per share (TTM) $12.675

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Available Asset Types Stock Fee Option Fee Account Fee ETF Transaction Cost Feature Table description
Wealthsimple Trade
Stocks, ETFs
Get a $50 bonus when you open a Wealthsimple Trade account and deposit and trade at least $150.
Pay no commissions when you trade Canadian stocks and ETFs with Wealthsimple Trade.
BMO InvestorLine
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$9.95 + $1.25 per options contract
$0 if conditions met, otherwise $25/quarter
$0 - $9.95
Buy and sell a select group of Canada’s most popular ETFs without paying commissions.

An easy-to-use online trading platform with access to research, tools, and the option to access InvestorLine adviceDirect for additional professional support.
Scotia iTRADE
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
$9.99 + $1.25 contract ($4.99 + $1.25 contract if completed 150 trades or more a quarter)
$9.99 ($4.99 if completed 150 trades or more a quarter)
Pay no annual account fees.
Buy, sell and trade ETFs, Equities, Options and more with competitive commissions.
CIBC Investor's Edge
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95 - $6.95
$4.95 - $6.95 (+$1.25 per contract)
$0 if conditions met, otherwise $100/year
$4.95 - $6.95 is applicable for online stock, ETF and option trades only. Pay $4.95 when you qualify as an Active Trader (trade 150+ times per quarter).
An intuitive and easy-to-use platform with access to a variety of tools that help you make smart decisions and trade with confidence.
Interactive Brokers
Stocks, Bonds, Options, ETFs, Currencies, Futures
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
Min. $1.00, Max. 0.5% of trade value
Extensive trading capabilities and global investment tracking.
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$9.95 + $1 per contract
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
Qtrade Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$6.95 - $8.75 + $1.25 per contract
$0 if conditions met, otherwise $25/quarter
$0 - $8.75
Get up to 50 free trades. Be one of the first 100 new Qtrade clients to use the promo code 50FREETRADES and deposit a minimum of $10,000 (or top up to $15,000 to get $150 transfer fees waived). Valid until September 30, 2021.
Qtrade Direct Investing offers low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options. Trade 100 ETFs free of charge and thousands more for $8.75 or lower.

Compare up to 4 providers

Online stock trading

Medifast price performance over time

Historical closes compared with the last close of $219.55

1 week (2021-09-13) -5.87%
1 month (2021-08-20) -1.49%
3 months (2021-06-18) -16.67%
6 months (2021-03-19) -7.88%
1 year (2020-09-18) 26.46%
2 years (2019-09-20) 103.31%
3 years (2018-09-20) 2.60%
5 years (2016-09-20) 480.97%

Is Medifast under- or over-valued?

Valuing Medifast stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medifast's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Medifast's P/E ratio

Medifast's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, Medifast stocks trade at around 17x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the stocks or simply that they're under-valued.

Medifast's PEG ratio

Medifast's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.95. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Medifast's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.

Medifast's EBITDA

Medifast's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$206.2 million.

The EBITDA is a measure of a Medifast's overall financial performance and is widely used to measure a its profitability.

Medifast financials

Revenue TTM USD$1.3 billion
Operating margin TTM 15.57%
Gross profit TTM USD$697.8 million
Return on assets TTM 41.5%
Return on equity TTM 96.64%
Profit margin 11.84%
Book value $16.656
Market capitalisation USD$2.6 billion

TTM: trailing 12 months

How to short and sell Medifast stocks

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "MED.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 341,004 Medifast stocks held short by investors – that's known as Medifast's "short interest". This figure is 17% down from 410,954 last month.

There are a few different ways that this level of interest in shorting Medifast stocks can be evaluated.

Medifast's "short interest ratio" (SIR)

Medifast's "short interest ratio" (SIR) is the quantity of Medifast stocks currently shorted divided by the average quantity of Medifast stocks traded daily (recently around 120496.1130742). Medifast's SIR currently stands at 2.83. In other words for every 100,000 Medifast stocks traded daily on the market, roughly 2830 stocks are currently held short.

However Medifast's short interest can also be evaluated against the total number of Medifast stocks, or, against the total number of tradable Medifast stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Medifast's short interest could be expressed as 0.03% of the outstanding stocks (for every 100,000 Medifast stocks in existence, roughly 30 stocks are currently held short) or 0.033% of the tradable stocks (for every 100,000 tradable Medifast stocks, roughly 33 stocks are currently held short).

Such a low SIR usually points to an optimistic outlook for the stock price, with fewer people currently willing to bet against Medifast.

Find out more about how you can short Medifast stock.

Medifast stock dividends


Dividend payout ratio: 42.51% of net profits

Recently Medifast has paid out, on average, around 42.51% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.59% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Medifast shareholders could enjoy a 2.59% return on their shares, in the form of dividend payments. In Medifast's case, that would currently equate to about $5.1 per share.

While Medifast's payout ratio might seem fairly standard, it's worth remembering that Medifast may be investing much of the rest of its net profits in future growth.

Medifast's most recent dividend payout was on 8 November 2021. The latest dividend was paid out to all shareholders who bought their stocks by 20 September 2021 (the "ex-dividend date").

Medifast stock price volatility

Over the last 12 months, Medifast's stocks have ranged in value from as little as $137.181 up to $335.1738. A popular way to gauge a stock's volatility is its "beta".

MED.US volatility(beta: 1.41)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a stocks volatility in relation to the market. The market (NYSE average) beta is 1, while Medifast's is 1.4061. This would suggest that Medifast's stocks are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Medifast overview

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands. The company markets its products through point of sale transactions over ecommerce platform and its franchisee system. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site